Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
Michelle J NaughtonHeshan LiuDrew K SeislerJennifer G Le-RademacherJane M ArmerJill M OliveriJeffrey A SloanKaren HockMichael SchwartzGary UnzeitigMarianne MelnikLisa D YeeGini F FlemingJohn R TaylorCharles L LoprinziElectra D PaskettPublished in: Cancer (2020)
The tested interventions did not differ in preventing lymphedema or in HRQOL outcomes. African American women reported greater HRQOL impacts due to lymphedema symptoms than women of other races or ethnicities.